Business Context and Reporting Period
Company: ALPHA PRO TECH, LTD.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2002
Business Overview: The Company develops, manufactures, and markets disposable protective apparel, infection control products (masks/shields), extended care products, and consumer products (pet bedding/toys). Operations are divided into three segments: Apparel, Mask/Shield, and Extended Care. Products are sold primarily in the U.S. to medical, dental, industrial, and cleanroom markets.
Key Financial Metrics (Year Ended Dec 31, 2002)
| Metric | 2002 | 2001 |
|---|---|---|
| Net Sales | $21,354,000 | $21,333,000 |
| Gross Profit | $10,523,000 | $9,086,000 |
| Gross Margin | 49.3% | 42.6% |
| Net Income | $1,665,000 | $786,000 |
| Diluted EPS | $0.07 | $0.03 |
| Operating Cash Flow | $3,028,000 | $1,360,000 |
| Cash & Equivalents (End of Period) | $2,879,000 | $1,372,000 |
| Working Capital | $7,050,000 | $6,445,000 |
| Total Debt (Notes Payable) | $415,000 | $955,000 |
Material Changes vs. Prior Period
- Profitability Surge: Net income increased 111.8% to $1.665 million, driven primarily by a significant expansion in gross profit margins.
- Margin Expansion: Gross margin improved from 42.6% to 49.3%. Management attributes this to increased manufacturing in China at lower costs and the elimination of goodwill amortization under SFAS No. 142.
- Revenue Stagnation: Consolidated sales remained virtually flat (+0.1%), with growth in the pharmaceutical market offset by weakness in the medical and semiconductor cleanroom markets.
- Segment Performance: Apparel sales grew 3.7% to $14.6 million. Mask/Shield sales declined 8.3% to $4.8 million. Extended Care sales declined 3.4% to $2.0 million.
- Expense Management: Selling, General, and Administrative (SG&A) expenses decreased slightly by 0.6% despite higher executive bonuses ($291k in 2002 vs. $134k in 2001), due to reductions in travel and marketing costs.
Guidance, Outlook, and Risks
- Outlook: Management expects to remain profitable in 2003 and anticipates gross profit margins will remain strong. A slow recovery is expected in the semiconductor cleanroom market.
- Customer Concentration Risk: Sales to the largest customer, VWR Scientific, represented 64.5% of total sales in 2002. The loss of this customer would have a material adverse effect on the business.
- Manufacturing Strategy: The Company continues to shift manufacturing from Mexico to China to reduce costs. A Mexican facility lease was not renewed in 2002.
- Capital Allocation: The Company repurchased 930,900 shares of common stock for $802,000 in 2002. A new $500,000 buyback program was authorized in October 2002.
- Liquidity: The Company maintains a $3.5 million line of credit with $2.438 million unused as of year-end. Management believes cash from operations and the credit facility are sufficient for future needs.
- Market Risks: Results could be negatively affected by foreign currency exchange rate fluctuations due to manufacturing in Mexico and China. The Company does not hedge these risks.
Investor Verification Checklist
- Customer Dependency: Verify the stability of the relationship with VWR Scientific, which accounts for nearly two-thirds of revenue.
- Margin Sustainability: Assess whether the 49.3% gross margin is sustainable given the shift to Chinese manufacturing and potential raw material cost fluctuations.
- Market Recovery: Monitor the recovery timeline for the semiconductor cleanroom market, which currently drags on Apparel segment growth.
- Debt Covenants: Review the terms of the $3.5 million credit facility and equipment loans to ensure compliance with covenants.
- Share Repurchases: Evaluate the impact of ongoing share buybacks on cash reserves and future capital expenditure capabilities.